Anti Malaria Campaign, Ministry of Health, Colombo, Sri Lanka.
Department of Parasitology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
Malar J. 2024 Jun 22;23(1):195. doi: 10.1186/s12936-024-05014-w.
Imported malaria continues to be reported in Sri Lanka after it was eliminated in 2012, and a few progress to life-threatening severe malaria.
Data on imported malaria cases reported in Sri Lanka from 2013 to 2023 were extracted from the national malaria database maintained by the Anti Malaria Campaign (AMC) of Sri Lanka. Case data of severe malaria as defined by the World Health Organization were analysed with regard to patients' general characteristics and their health-seeking behaviour, and the latter compared with that of uncomplicated malaria patients. Details of the last three cases of severe malaria in 2023 are presented.
532 imported malaria cases were diagnosed over 11 years (2013-2023); 46 (8.6%) were severe malaria, of which 45 were Plasmodium falciparum and one Plasmodium vivax. Most severe malaria infections were acquired in Africa. All but one were males, and a majority (87%) were 26-60 years of age. They were mainly Sri Lankan nationals (82.6%). Just over half (56.5%) were treated at government hospitals. The average time between arrival of the person in Sri Lanka and onset of illness was 4 days. 29 cases of severe malaria were compared with 165 uncomplicated malaria cases reported from 2015 to 2023. On average both severe and uncomplicated malaria patients consulted a physician equally early (mean = 1 day) with 93.3% of severe malaria doing so within 3 days. However, the time from the point of consulting a physician to diagnosis of malaria was significantly longer (median 4 days) in severe malaria patients compared to uncomplicated patients (median 1 day) (p = 0.012) as was the time from onset of illness to diagnosis (p = 0.042). All severe patients recovered without sequelae except for one who died.
The risk of severe malaria among imported cases increases significantly beyond 5 days from the onset of symptoms. Although patients consult a physician early, malaria diagnosis tends to be delayed by physicians because it is now a rare disease. Good access to expert clinical care has maintained case fatality rates of severe malaria at par with those reported elsewhere.
斯里兰卡于 2012 年消除疟疾后,仍有输入性疟疾病例报告,其中少数病例发展为危及生命的重症疟疾。
从斯里兰卡抗疟运动(AMC)维护的国家疟疾数据库中提取 2013 年至 2023 年报告的输入性疟疾病例数据。根据世界卫生组织的定义,对重症疟疾病例的数据进行分析,包括患者的一般特征及其就医行为,并将后者与无并发症疟疾患者进行比较。报告了 2023 年最后三例重症疟疾的详细情况。
11 年间共诊断出 532 例输入性疟疾病例(2013-2023 年);其中 46 例(8.6%)为重症疟疾,其中 45 例为恶性疟原虫,1 例为间日疟原虫。大多数重症疟疾感染发生在非洲。除 1 例外,其余均为男性,大多数(87%)年龄在 26-60 岁之间。他们主要是斯里兰卡国民(82.6%)。超过一半(56.5%)在政府医院接受治疗。患者抵达斯里兰卡和发病之间的平均时间为 4 天。将 29 例重症疟疾与 2015 年至 2023 年期间报告的 165 例无并发症疟疾病例进行比较。平均而言,重症和无并发症疟疾患者就医时间同样早(平均 1 天),93.3%的重症疟疾患者在 3 天内就医。然而,从看医生到诊断疟疾的时间在重症疟疾患者中明显较长(中位数 4 天),与无并发症患者(中位数 1 天)相比(p=0.012),从发病到诊断的时间也较长(p=0.042)。除 1 例死亡外,所有重症患者均康复,无后遗症。
症状出现后 5 天以上,输入性疟疾病例发生重症疟疾的风险显著增加。尽管患者就医时间较早,但由于疟疾现在是一种罕见疾病,医生往往会延迟诊断。良好的获得专家临床护理使重症疟疾的病死率保持在与其他地方报告的病死率相当的水平。